Latest Breaking News On - Company or innocan - Page 1 : vimarsana.com

Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6 8 Million

/PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on.

Tel avivInnocan pharmaIris bincovichRoni kamhiBi sky global ltdCompany or innocanInnocan pharma corporationPrnewswire innocan pharma corporationPharma corporationPain managementConsumer wellness

Innocan Pharma Corporation: Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6 8 Million

HERZLIYA, Israel and CALGARY, AB, May 27, 2024 /PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company

Tel avivIris bincovichRoni kamhiInnocan pharmaBi sky global ltdCompany or innocanPrnewswire innocan pharma corporationPharma corporationPlasma followingPain managementConsumer wellnessIhr portfolio

Innocan Pharma Corporation: Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13 7M

Innocan Pharma Corporation: Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13 7M
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Tel avivInnocan pharmaDennis riedlIris bincovichRoni kamhiInnocan pharma corporationBi sky global ltdPrnewswire innocan pharma corporationCompany or innocanPharma corporationPain managementConsumer wellness

Innocan Pharma Reports Full Year 2023 Results With Revenues Up Nearly 6X To $13 7M

Innocan Pharma Reports Full Year 2023 Results With Revenues Up Nearly 6X To $13 7M
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Tel avivInnocan pharmaIris bincovichRoni kamhiPrnewswire innocan pharma corporationCompany or innocanInnocan pharma corporationBi sky global ltdPharma corporationPain managementConsumer wellness

Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13 7M

HERZLIYA, Israel and CALGARY, Alberta, April 1, 2024 /CNW/ Innocan Pharma Corporation , a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies.

Tel avivIris bincovichInnocan pharmaRoni kamhiCompany or innocanBi sky global ltdInnocan pharma corporationPharma corporationPain managementConsumer wellnessCanada newswire